HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

H M Vordermeier Selected Research

Bovine Tuberculosis

12/2013Upregulation of IL-17A, CXCL9 and CXCL10 in early-stage granulomas induced by Mycobacterium bovis in cattle.
3/2013The consequences of vaccination with the Johne's disease vaccine, Gudair, on diagnosis of bovine tuberculosis.
3/2012Evaluation of gamma interferon (IFN-γ)-induced protein 10 responses for detection of cattle infected with Mycobacterium bovis: comparisons to IFN-γ responses.
11/2011Development and evaluation of an enzyme-linked immunosorbent assay for use in the detection of bovine tuberculosis in cattle.
8/2010Comparison of tuberculin activity using the interferon-gamma assay for the diagnosis of bovine tuberculosis.
10/2006Field evaluation of a novel differential diagnostic reagent for detection of Mycobacterium bovis in cattle.
6/2006Development of vaccines against bovine tuberculosis.
6/2005Vaccination of cattle with Mycobacterium bovis culture filtrate proteins and CpG oligodeoxynucleotides induces protection against bovine tuberculosis.
11/2003Use of mycobacterial peptides and recombinant proteins for the diagnosis of bovine tuberculosis in skin test-positive cattle.
11/2003Modulation of the bovine delayed-type hypersensitivity responses to defined mycobacterial antigens by a synthetic bacterial lipopeptide.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


H M Vordermeier Research Topics

Disease

18Bovine Tuberculosis
12/2013 - 05/2000
13Infections
02/2018 - 05/2000
13Tuberculosis (Tuberculoses)
04/2014 - 12/2000
3Hypersensitivity (Allergy)
02/2010 - 11/2003
2Granuloma
12/2017 - 12/2013
2Paratuberculosis (Johne's Disease)
03/2013 - 11/2003
1Cutaneous Tuberculosis (Scrofuloderma)
11/2003
1Animal Diseases
08/2002

Drug/Important Bio-Agent (IBA)

13Tuberculin (PPD)IBA
02/2018 - 05/2000
12AntigensIBA
02/2018 - 05/2000
10VaccinesIBA
04/2014 - 06/2000
6Proteins (Proteins, Gene)FDA Link
02/2018 - 01/2003
6Interferon-gamma (Interferon, gamma)IBA
03/2012 - 05/2000
5CytokinesIBA
12/2017 - 05/2000
5Indicators and Reagents (Reagents)IBA
03/2012 - 12/2002
4Peptides (Polypeptides)IBA
11/2003 - 05/2001
2Biomarkers (Surrogate Marker)IBA
12/2013 - 03/2012
2Messenger RNA (mRNA)IBA
12/2013 - 03/2012
1ChemokinesIBA
12/2013
1Interleukin-22 (IL-22)IBA
12/2013
1Interleukin-17 (Interleukin 17)IBA
12/2013
1AerosolsIBA
03/2012
1EnzymesIBA
11/2011
1ImmunosorbentsIBA
11/2011
1Interleukin-10 (Interleukin 10)IBA
11/2008
1Isoniazid (Ftivazide)FDA LinkGeneric
11/2008
1Immunoglobulin G (IgG)IBA
11/2006
1CPG-oligonucleotideIBA
06/2005
1Immunologic Factors (Immunomodulators)IBA
06/2005
1OligodeoxyribonucleotidesIBA
06/2005
1Recombinant ProteinsIBA
11/2003
1LipopeptidesIBA
11/2003
1Calcitriol (Calcijex)FDA LinkGeneric
11/2003
1A-Form DNA (A-DNA)IBA
01/2003
1DNA (Deoxyribonucleic Acid)IBA
01/2003
1DNA VaccinesIBA
01/2003
1Subunit VaccinesIBA
12/2002
1Tuberculosis VaccinesIBA
12/2002
1Interleukin-12 (IL 12)IBA
08/2002
1Interleukin-4 (Interleukin 4)IBA
09/2000
1Interleukin-2 (IL2)IBA
05/2000
1AG 85IBA
05/2000

Therapy/Procedure

1Lasers (Laser)
12/2013
1Intradermal Injections
11/2006
1Immunomodulation
05/2001